ProfileGDS4718 / 228133_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 24% 90% 19% 20% 23% 19% 25% 14% 24% 16% 18% 23% 22% 22% 25% 20% 18% 21% 15% 26% 20% 23% 26% 22% 23% 19% 19% 21% 18% 19% 44% 20% 26% 21% 21% 24% 17% 18% 92% 14% 23% 33% 27% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1693320
GSM549102patient 115, normal, homogenized [OPG study]4.2978324
GSM549104patient 119, normal, homogenized [OPG study]9.1790
GSM549108patient 138, normal, homogenized [OPG study]4.1498619
GSM549119patient 077, normal, homogenized [OPG study]4.1566320
GSM549133patient 032, cancer, homogenized [OPG study]4.1918723
GSM549139patient 042, cancer, homogenized [OPG study]4.0809119
GSM549099patient 107, normal, homogenized [OPG study]4.3478425
GSM549109patient 139, normal, homogenized [OPG study]3.938314
GSM549110patient 046, normal, homogenized [OPG study]4.2977724
GSM549114patient 063, normal, homogenized [OPG study]3.9726816
GSM549122patient 082, normal, homogenized [OPG study]4.0811118
GSM549134patient 033, cancer, homogenized [OPG study]4.2530623
GSM549136patient 036, cancer, homogenized [OPG study]4.1530622
GSM549140patient 044, cancer, homogenized [OPG study]4.1917422
GSM549111patient 047, normal, homogenized [OPG study]4.2965725
GSM549113patient 057, normal, homogenized [OPG study]4.1079920
GSM549132patient 031, cancer, homogenized [OPG study]4.06718
GSM549137patient 038, cancer, homogenized [OPG study]4.1837121
GSM549142patient 047, cancer, homogenized [OPG study]4.036215
GSM549100patient 110, normal, homogenized [OPG study]4.3789626
GSM549107patient 135, normal, homogenized [OPG study]4.1039320
GSM549115patient 068, normal, homogenized [OPG study]4.2023323
GSM549116patient 072, normal, homogenized [OPG study]4.3799126
GSM549120patient 078, normal, homogenized [OPG study]4.1984122
GSM549131patient 030, cancer, homogenized [OPG study]4.1954323
GSM549118patient 074, normal, homogenized [OPG study]4.1086419
GSM549129patient 027, cancer, homogenized [OPG study]4.1209219
GSM549123patient 088, normal, homogenized [OPG study]4.1750821
GSM549124patient 006, cancer, homogenized [OPG study]4.111218
GSM549126patient 015, cancer, homogenized [OPG study]4.1083119
GSM549128patient 025, cancer, homogenized [OPG study]5.1497344
GSM549103patient 117, normal, homogenized [OPG study]4.1866220
GSM549117patient 073, normal, homogenized [OPG study]4.3334626
GSM549138patient 041, cancer, homogenized [OPG study]4.1671621
GSM549141patient 045, cancer, homogenized [OPG study]4.1275121
GSM549130patient 028, cancer, homogenized [OPG study]4.3273624
GSM549101patient 111, normal, homogenized [OPG study]4.0454217
GSM549105patient 128, normal, homogenized [OPG study]4.0728718
GSM549106patient 134, normal, homogenized [OPG study]9.7431192
GSM549112patient 048, normal, homogenized [OPG study]3.9293914
GSM549125patient 011, cancer, homogenized [OPG study]4.2831123
GSM549127patient 024, cancer, homogenized [OPG study]4.6634433
GSM549135patient 035, cancer, homogenized [OPG study]4.3731327